Skip to main content
. 2015 May 29;17(2):192–198. doi: 10.5853/jos.2015.17.2.192

Table 1. Patient characteristics.

graphic file with name jos-17-192-i001.jpg

*antiplatelet agent: aspirin, clopidogrel, triflusal, cilostazol; Potentiating drugs12: cardiovascular (amiodarone, diltiazem, propafenone, propranolol), antibiotic (erythromycin, fluconazole, isoniazid, metronidazol); Attenuating drugs12: antibiotic (Rifampin), cardiovascular (telmisartan).